China's healthcare services provider iKang Guobin Healthcare Group is aiming to raise up to $150 million in an initial public offering (IPO) on the Nasdaq stock market—the latest Chinese company to attempt a listing in the U.S. market.

The Beijing-based company reported revenue of $134 million in the 2012 fiscal year that ended in March 2013, 43 percent up year on year.

Its net profit rose by 25 percent year on year to $12 million, according to its financial reports.

The company, in which Goldman Sachs Group Inc. and Government of Singapore Investment Corp. both have stakes, has 40 health examination and medical treatment centers in 12 cities in China.

Analysts said iKang Guobin is highly likely to be the first Chinese medical examination provider to be listed on the U.S. market.